Vg Life Sciences Inc
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. It offers VG1177, a solution that deploys a synthesized peptide, which uses its superior binding abilities to eliminate the unwanted Class II-associated invariant chain peptide (CLIP) that is … Read more
Vg Life Sciences Inc (VGLS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2015: 0.011x
Based on the latest financial reports, Vg Life Sciences Inc (VGLS) has a cash flow conversion efficiency ratio of 0.011x as of September 2015.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-48.32K) by net assets ($-4.34 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Vg Life Sciences Inc - Cash Flow Conversion Efficiency Trend (2000–2014)
This chart illustrates how Vg Life Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Vg Life Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vg Life Sciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kaiser Group Holdings Inc
PINK:KGHI
|
-0.691x |
|
Clean Energy Pathway
PINK:CPWY
|
0.000x |
|
Micro Imaging Technology Inc
PINK:MMTC
|
0.036x |
|
Mondial Ventures Inc
PINK:MNVN
|
0.195x |
|
Strategic Management and Opportunity Corporation
PINK:SMPP
|
0.215x |
|
Extreme Biodiesel In
PINK:XTRM
|
0.095x |
|
U.S. Wind Farming Inc
PINK:USWF
|
0.031x |
|
Environmental Service Professionals Inc
PINK:EVSP
|
0.027x |
Annual Cash Flow Conversion Efficiency for Vg Life Sciences Inc (2000–2014)
The table below shows the annual cash flow conversion efficiency of Vg Life Sciences Inc from 2000 to 2014.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2014-12-31 | $-4.51 Million | $-1.91 Million | 0.424x | +82.43% |
| 2013-12-31 | $-4.47 Million | $-1.04 Million | 0.232x | +1.58% |
| 2012-12-31 | $-4.20K | $-959.79 | 0.229x | -77.24% |
| 2011-12-31 | $-1.01 Million | $-1.02 Million | 1.005x | +89.30% |
| 2006-12-31 | $-7.32 Million | $-3.89 Million | 0.531x | +178.82% |
| 2005-12-31 | $3.20 Million | $-2.15 Million | -0.674x | -180.65% |
| 2004-12-31 | $4.27 Million | $-1.03 Million | -0.240x | -209.73% |
| 2003-12-31 | $-4.46 Million | $-974.66K | 0.219x | +240.01% |
| 2002-12-31 | $-4.24 Million | $-272.97K | 0.064x | -26.58% |
| 2001-12-31 | $-4.10 Million | $-359.66K | 0.088x | -86.20% |
| 2000-12-31 | $-201.79K | $-128.08K | 0.635x | -- |